It has come to our attention that in this Article, owing to an error during the production process, ‘Brca2’ was mislabelled as ‘Brca1’ in Fig. 4b, and ‘Parp1’ was mislabelled as ‘Ptip’ in Fig. 4e. These errors have been corrected in the online versions of the paper.
Additional information
The online version of the original article can be found at 10.1038/nature18325
Rights and permissions
About this article
Cite this article
Chaudhuri, A., Callen, E., Ding, X. et al. Erratum: Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature 539, 456 (2016). https://doi.org/10.1038/nature19826
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature19826
This article is cited by
-
Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Nature Cancer (2022)
-
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer
British Journal of Cancer (2021)
-
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
Nature Communications (2020)
-
AND-1 fork protection function prevents fork resection and is essential for proliferation
Nature Communications (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
